Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish

Tilray Inc (NASDAQ:TLRY) earned a repetition ‘Buy’ standing from Jefferies analysts aft what it described arsenic a coagulated 3rd 4th net report, pointing to improving fundamentals and accrued visibility into the company’s medium-term outlook.

The brokerage reiterated a terms people of $24, implying important upside if execution continues arsenic expected. Shares traded up 8% astatine $6 connected Thursday afternoon.

In the 3rd quarter, Tilray reported gross maturation of 11.3%, exceeding expectations of astir 7.5%. The show was driven chiefly by spot successful the cannabis segment, wherever income roseate 19%, offsetting continued weakness successful trade beer, which declined 24%.

Gross margins came successful somewhat beneath expectations, missing by astir 150 ground points, though adjusted EBITDA was broadly successful enactment astatine astir $11 million.

The institution reaffirmed its fiscal 2026 adjusted EBITDA guidance scope of $62 cardinal to $72 million, which Jefferies said implies stronger borderline enlargement successful the 4th quarter.

Jefferies highlighted planetary cannabis operations arsenic a cardinal country of outperformance. Sales successful that conception accrued 73% year-over-year, good up of anterior trends.

While overseas speech contributed to the result, the steadfast noted that underlying maturation remained strong, supported by proviso concatenation improvements, expanding diligent adoption, and enlargement into newer markets.

Recent strategical developments were besides viewed positively. Partnerships with Carlsberg and BrewDog are expected to fortify Tilray’s level and supply greater visibility into aboriginal growth.

Jefferies besides incorporated the anticipated interaction of the BrewDog transaction into its forecasts, estimating it could lend astir $200 cardinal successful gross and betwixt $6 cardinal and $8 cardinal successful adjusted EBITDA by fiscal 2027.

Looking ahead, Jefferies expects fourth-quarter gross of astir $233 cardinal and EBITDA of $39 million, with full-year projections of astir $1.1 cardinal successful gross and $95 cardinal successful EBITDA.

The steadfast described the company’s near-term trajectory arsenic positive, citing improved proviso conditions and continued spot successful higher-margin cannabis markets, peculiarly internationally, portion noting that trade brew remains a softer conception and margins volition proceed to beryllium intimately watched.

In the longer-term, Jefferies believes Tilray is positioned to payment from a much favorable merchandise mix, planetary expansion, and imaginable regulatory changes successful the United States.

The firm’s valuation is based connected a 27x aggregate applied to its fiscal 2027 EBITDA estimation of $95 million, reflecting assurance successful the company’s quality to standard net implicit clip portion maintaining equilibrium expanse flexibility for imaginable acquisitions.